These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Analysis by infrared spectrometry of renal calculi in whose composition there are porphyrins]. Traba ML; Perpiña J; Enriquez de Salamanca R Actas Urol Esp; 1987; 11(3):309-12. PubMed ID: 3661268 [No Abstract] [Full Text] [Related]
25. Risk of kidney stones. Ettinger B JAMA; 1982 Oct; 248(16):1971. PubMed ID: 7120618 [No Abstract] [Full Text] [Related]
26. Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites. Werness PG; Bergert JH; Smith LH J Lab Clin Med; 1982 Feb; 99(2):254-62. PubMed ID: 7061920 [TBL] [Abstract][Full Text] [Related]
27. Excretion of triamterene and its metabolite in triamterene stone patients. Ettinger B J Clin Pharmacol; 1985; 25(5):365-8. PubMed ID: 4031113 [TBL] [Abstract][Full Text] [Related]
29. Drug-induced renal stones: incidence, clinical expression and stone analysis. Rapado A; Traba ML; Caycho C; Cifuentes-Delatte L Contrib Nephrol; 1987; 58():25-9. PubMed ID: 2826078 [No Abstract] [Full Text] [Related]
30. [Identification and quantification of various porphyrins as components in a peculiar type of renal calculus]. Traba ML; Perpiñá J; Enríquez de Salamanca R Arch Esp Urol; 1985; 38(6):601-4. PubMed ID: 3833067 [No Abstract] [Full Text] [Related]